Lv62
2638 积分 2024-10-21 加入
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
1个月前
已完结
Sacituzumab Tirumotecan in EGFR-TKI-Resistant, EGFR-Mutated Advanced NSCLC
1个月前
已完结
Herpes Zoster
1个月前
已完结
Selective targeting of endothelial and perivascular angiocrine ROCK2 treats liver fibrosis
1个月前
已完结
Single-cell perturbations decipher ribosomal stress-surveillance regulators in type 2 diabetes
2个月前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
3个月前
已完结
Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma
3个月前
已完结
Targeting tumors with IL-21 reshapes the tumor microenvironment by proliferating PD-1intTim-3–CD8+ T cells
3个月前
已完结
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
3个月前
已完结
Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNA
3个月前
已完结
皖公网安备34019202002308
